» Articles » PMID: 22123079

Proteomic Analysis of the Nucleus Accumbens in Rhesus Monkeys of Morphine Dependence and Withdrawal Intervention

Overview
Journal J Proteomics
Publisher Elsevier
Specialty Biochemistry
Date 2011 Nov 30
PMID 22123079
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

It has been known that the reinforcing effects and long-term consequences of morphine are closely associated with nucleus accumbens (NAc) in the brain, a key region of the mesolimbic dopamine pathway. However, the proteins involved in neuroadaptive processes and withdrawal symptom in primates of morphine dependence have not been well explored. In the present study, we performed proteomes in the NAc of rhesus monkeys of morphine dependence and withdrawal intervention with clonidine or methadone. Two-dimensional electrophoresis was used to compare changes in cytosolic protein abundance in the NAc. We found a total of 46 proteins differentially expressed, which were further identified by mass spectrometry analysis. The identified proteins can be classified into 6 classes: metabolism and mitochondrial function, synaptic transmission, cytoskeletal proteins, oxidative stress, signal transduction and protein synthesis and degradation. Importantly, we discovered 14 proteins were significantly but similarly altered after withdrawal therapy with clonidine or methadone, revealing potential pharmacological strategies or targets for the treatment of morphine addiction. Our study provides a comprehensive understanding of the neuropathophysiology associated with morphine addiction and withdrawal therapy in primate, which is helpful for the development of opiate withdrawal pharmacotherapies.

Citing Articles

iTRAQ proteomic analysis of the anterior insula in morphine-induced conditioned place preference rats with high-frequency deep brain stimulation intervention.

Chang H, Wang Y, Hui L, Diao Y, Ma P, Li X Addict Biol. 2025; 30(1):e70014.

PMID: 39835462 PMC: 11747870. DOI: 10.1111/adb.70014.


Amelioration of morphine withdrawal syndrome by systemic and intranasal administration of mesenchymal stem cell-derived secretome in preclinical models of morphine dependence.

Quezada M, Ponce C, Berrios-Carcamo P, Santapau D, Gallardo J, De Gregorio C CNS Neurosci Ther. 2023; 30(4):e14517.

PMID: 37927136 PMC: 11017443. DOI: 10.1111/cns.14517.


Impact of Opioids on Cellular Metabolism: Implications for Metabolic Pathways Involved in Cancer.

Tarazi D, Maynes J Pharmaceutics. 2023; 15(9).

PMID: 37765194 PMC: 10534826. DOI: 10.3390/pharmaceutics15092225.


Functional genomic mechanisms of opioid action and opioid use disorder: a systematic review of animal models and human studies.

Falconnier C, Caparros-Roissard A, Decraene C, Lutz P Mol Psychiatry. 2023; 28(11):4568-4584.

PMID: 37723284 PMC: 10914629. DOI: 10.1038/s41380-023-02238-1.


The ubiquitin-proteasome system and learning-dependent synaptic plasticity - A 10 year update.

Patrick M, Omar N, Werner C, Mitra S, Jarome T Neurosci Biobehav Rev. 2023; 152:105280.

PMID: 37315660 PMC: 11323321. DOI: 10.1016/j.neubiorev.2023.105280.